OVID - Ovid Therapeutics Inc.

QQQ $ 461.29 $ -12.39 (-2.62 %)

DIA $ 410.26 $ -5.96 (-1.43 %)

SPY $ 551.70 $ -9.13 (-1.63 %)

TLT $ 97.57 $ 1.08 (1.12 %)

GLD $ 230.29 $ -1.00 (-0.43 %)

Previous Close

$ 1.09

Open

$ 1.10

Bid

$ 1.07 x 300

Ask

-- x --

Day's Range

$ 1.07 - $ 1.11

52 Week Range

$ 0.68 - $ 4.10

Volume

191,435

Average Volume

Market Cap

80.2M

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-08-2024	12-31-2023	10-K
4	11-03-2023	09-30-2023	10-Q
5	08-04-2023	06-30-2023	10-Q
6	05-05-2023	03-31-2023	10-Q
7	03-13-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-15-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-15-2021	12-31-2020	10-K
16	11-13-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-11-2020	12-31-2019	10-K
20	11-08-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	03-07-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	03-29-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-10-2017	06-30-2017	10-Q
30	06-13-2017	03-31-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Expert Outlook: Ovid Therapeutics Through ...
08/19/2024 12:00:37

HC Wainwright & Co. Reiterates Buy on Ovid...
08/19/2024 11:25:48

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Ovid Therapeutics (NASDAQ:OVID) with a Buy and maintains $3 pr...

The Latest Analyst Ratings For Ovid Therap...
07/26/2024 18:01:08

HC Wainwright & Co. Reiterates Buy on Ovid...
07/26/2024 11:25:49

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Ovid Therapeutics (NASDAQ:OVID) with a Buy and maintains $3 pr...

Ovid Therapeutics Announces eNeuro Publish...
07/10/2024 12:02:07

Sustained exposure to OV329 in preclinical models reduced GABA-aminotransferase (GABA-AT) activity, increased steady state GABA...

HC Wainwright & Co. Reiterates Buy on Ovid...
07/02/2024 10:23:50

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Ovid Therapeutics (NASDAQ:OVID) with a Buy and maintains $3 pr...

Ovid Therapeutics And Graviton Bioscience ...
07/01/2024 12:03:48

The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no ...

BTIG Maintains Buy on Ovid Therapeutics, L...
06/18/2024 16:56:29

BTIG analyst Thomas Shrader maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price target from $11 to $5.

B. Riley Securities Maintains Buy on Ovid ...
06/18/2024 15:10:44

B. Riley Securities analyst Kalpit Patel maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price target fr...

Citigroup Maintains Neutral on Ovid Therap...
06/18/2024 14:44:28

Citigroup analyst Yigal Nochomovitz maintains Ovid Therapeutics (NASDAQ:OVID) with a Neutral and lowers the price target fro...

Evaluating Ovid Therapeutics: Insights Fro...
06/18/2024 13:00:43

HC Wainwright & Co. Maintains Buy on Ovid ...
06/18/2024 12:20:01

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price...

nasdaq-surges-over-200-points-aarons-shares-jump

Nasdaq Surges Over 200 Points; Aaron's Sha...
06/17/2024 18:40:51

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

Crude Oil Rises 1%; Mustang Bio Shares Spi...
06/17/2024 16:16:09

US Stocks Mixed; Dow Tumbles Over 100 Points
06/17/2024 13:40:41

whats-going-on-with-ovid-therapeutics-after-takedas-two-phase-3-epilepsy-studies-fail

What's Going On With Ovid Therapeutics Aft...
06/17/2024 12:58:59

Takeda Pharmaceutical reveals Phase 3 study data for Soticlestat (TAK-935) in treating Dravet and Lennox-Gastaut syndromes. In ...

why-nurix-therapeutics-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Why Nurix Therapeutics Shares Are Trading ...
06/17/2024 12:43:16

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
06/17/2024 12:07:49